Acino ? Delivering Health
Acino ? Delivering Health
Acino ? Delivering Health
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Acino</strong>’s development pipeline<br />
Preclinical<br />
development<br />
Oral<br />
Depression<br />
Oral<br />
Iron overload, Thalassemia<br />
TDS<br />
Parkinson’s disease<br />
TDS, Fentanyl 3-day (low load)<br />
EU & US, Pain<br />
Implant, Goserelin Japan<br />
Prostate / Mamma carcinoma<br />
(updated March 2012)<br />
5<br />
Clinical<br />
Phase I / Pilot<br />
Oral<br />
Schizophrenia<br />
Oral<br />
Pain<br />
TDS<br />
Pain<br />
TDS<br />
Alzheimer’s disease<br />
Oral*<br />
CNS/Pain<br />
Oral*<br />
Cancer<br />
Oral dispersible*<br />
Urology<br />
* Projects taken over from Mepha. Several additional projects<br />
in evaluation.<br />
Undisclosed:<br />
Additional customer projects in different stages of development.<br />
Clinical<br />
Phase III / Pivotal<br />
Oral<br />
Schizophrenia<br />
Oxycodone Matrix<br />
Pain<br />
TDS, Rivastigmine USA<br />
Alzheimer’s disease<br />
I.V. injection, Iclaprim<br />
Infection<br />
TDS, Contraceptive; customer<br />
project Bayer <strong>Health</strong>care<br />
Legend:<br />
Oral<br />
Oral<br />
dispersible<br />
TDS Implant<br />
In registration<br />
7 4 4<br />
TDS, Rivastigmine EU<br />
Alzheimer’s disease<br />
Implant, Goserelin 3-month<br />
Prostate carcinoma<br />
Implant, Leuprorelin 1-month<br />
Prostate carcinoma<br />
Implant, Leuprorelin 3-month<br />
Prostate carcinoma<br />
20 Number of <strong>Acino</strong> own projects by stage<br />
NCE (new<br />
chemical entity)<br />
Customer<br />
project<br />
12
Change language